From Xanthine Oxidase Inhibition to <i>In Vivo</i> Hypouricemic Effect: An Integrated Overview of <i>In Vitro</i> and <i>In Vivo</i> Studies with Focus on Natural Molecules and Analogues

<div>Structures of olsalazine sodium, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, and Knoevenagel/tandem Knoevenagel and Michael adducts of cyclohexane-1,3-dione and aryl aldehydes.</div>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: From Xanthine Oxidase Inhibition to <i>In Vivo</i> Hypouricemic Effect: An Integrated Overview of <i>In Vitro</i> and <i>In Vivo</i> Studies with Focus on Natural Molecules and Analogues 

Figure 9 | From Xanthine Oxidase Inhibition to In Vivo Hypouricemic Effect: An Integrated Overview of In Vitro and In Vivo Studies with Focus on Natural Molecules and Analogues 